is janumet a glp-1 XR: Dosage & Side Effects Janumet 50/1000 mg 56 tablets
Description
LP3-R is a triple agonist targeting the glucagon-like peptide-1 (LP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
In my practice, GLP-1s are one of the tools I use for improving metabolic health
Terauchi, Y., Satoi, Y., Takeuchi, M
Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, and nearly 99% remained diabetes-free at 176 weeks | Eli Lilly and Company
Theyre easy to access and generally safe, but avoid the inner thigh to reduce the risk of hitting sensitive tissue
